June 5, 2026
May 31, 2026
May 31, 2026
May 20, 2026
May 19, 2026
April 15, 2026
CURE SYNGAP1 announces 2026 board of trustees transition – PR45
March 20, 2026
March 9, 2026
February 3, 2026
January 27, 2026
July 3, 2025
April 25, 2025
April 15, 2025
SynGAP Research Fund (SRF), dba Cure SYNGAP1, announces Board of Trustees Update 2025 – PR38
March 25, 2025
March 18, 2025
March 11, 2025
February 11, 2025
December 18, 2024
December 4, 2024
December 1, 2024
November 12, 2024
4M Therapeutics Awarded $120,000 Grant from SynGAP Research Fund to Evaluate GSK3β Inhibition in Preclinical SYNGAP1-Related Disorders Research (Press Release issued by 4MTx)
October 29, 2024
September 17, 2024
September 12, 2024
September 10, 2024
September 5, 2024
July 18, 2024
July 9, 2024
July 2, 2024
SRF launches the SYNGAP1 missense account with Nordmoe family donation – PR23
May 23, 2024
April 4, 2024
April 3, 2024
March 25, 2024
SynGAP Research Fund (SRF) announces changes to its board of directors – pr19
November 2, 2023
October 26, 2023
SynGAP Research Fund awards $100,000 for investigating the impact of SYNGAP1 missense variants using structural bioinformatics
October 19, 2023
August 16, 2023
April 5, 2023
SynGAP Research Fund awards a collaborative grant to Tang Lab & AXONIS Therapeutics
January 5, 2023
October 4, 2022
July 28, 2022
July 6, 2022
April 26, 2022
March 29, 2022
February 28, 2022
SynGAP research fund deploys #CouldItBeSYNGAP1 screening tool in partnership with probably genetic
February 22, 2022
October 13, 2021
June 8, 2021
May 3, 2021
February 2, 2021
SynGAP Research Fund Announces #SRFFrazier Grant to Dr. Thomas Frazier of John Carroll University
November 19, 2020
SynGAP Research Fund Announces Grant to Heller Lab of Neuroepigenetics